Xanthine derivatives as a2b adenosine receptor antagonists

Details Xanthine derivatives as a2b adenosine receptor antagonists Xanthine derivatives as a2b adenosine receptor antagonists

C - Chemistry, Metallurgy

07

D

C07D 473/06 (2006.01)

Patent

CA 2524778

Disclosed are compounds that are A2B adenosine receptor antagonists, useful for treating various disease states, including asthma and diarrhea.

L'invention concerne des composés qui sont des antagonistes du récepteur de l'adénosine A¿2B?, que l'on utilise pour le traitement de différents états pathologiques y compris l'asthme et la diarrhée.

Affiliated with

Also associated with

Rating

Xanthine derivatives as a2b adenosine receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Xanthine derivatives as a2b adenosine receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Xanthine derivatives as a2b adenosine receptor antagonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1422857